Back to Candriam S.C.A. Candriam S.C.A.

SNDXSNDX
19 quarters

Position history for Candriam S.C.A.Candriam S.C.A.'s holdings in SYNDAX PHARMACEUTICALS INC

Yes. Candriam S.C.A. holds 1,696,040 shares of SNDX (Syndax Pharmaceuticals), worth $37M, as of its Q2 2026 13F filing. It increased the position by 770,708 shares (+83.3%) from Q1 2026. Candriam S.C.A. has held SNDX since Q1 2023, across 14 quarterly 13F filings. SNDX is 0.2% of Candriam S.C.A.'s reported 13F portfolio.

Current Value

$37M

Current Shares

1.7M

Total Value Change

+$31.9M

Total Shares Change

+1.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+83.3%
$37M0.2%$21.86
54
2026-Q1
Unchanged
925,332
0.0%
$21.6M0.1%$21.40
0
2025-Q4
Unchanged
925,332
0.0%
$19.4M0.1%$20.74
0
2025-Q3
Increased
925,332
+37.1%
$14.2M0.1%$15.56
37
2025-Q2
Increased
675,085
+49.9%
$6.3M0.0%$9.04
38
2025-Q1
Decreased
450,435
-17.7%
$5.5M0.0%$13.18
0
2024-Q4
Decreased
547,165
-45.2%
$7.2M0.0%$12.52
0
2024-Q3
Increased
998,619
+2.9%
$19.2M0.1%$18.89
35
2024-Q2
Decreased
970,106
-7.2%
$19.9M0.1%$20.53
0
2024-Q1
Increased
1M
+2.4%
$24.9M0.2%$23.80
35
2023-Q4
Increased
1M
+325.4%
$22.1M0.2%$21.61
55
2023-Q3
Unchanged
240,010
0.0%
$3.5M0.0%$14.52
0
2023-Q2
Decreased
240,010
-5.8%
$5M0.0%$20.47
0
2023-Q1
New
254,874
-
$5M0.0%$20.66
37
2021-Q2
Exited
0
-100.0%
$00.0%$17.41
0
2021-Q1
Unchanged
25,671
0.0%
$548,0000.0%$20.96
0
2020-Q4
Decreased
25,671
-92.8%
$571,0000.0%$22.85
0
2020-Q3
Increased
358,372
+3.1%
$5.3M0.0%$14.02
28
2020-Q2
New
347,458
-
$5.2M0.1%$14.46
37

Other major holders of SNDX: WELLINGTON MANAGEMENT GROUP LLP, BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used